Human papillomavirus 16 E6 oncoprotein binds to interferon regulatory factor-3 and inhibits its transcriptional activity

  1. Lucienne V. Ronco1,
  2. Alla Y. Karpova1,
  3. Marc Vidal2, and
  4. Peter M. Howley1,3
  1. 1Department of Pathology, Harvard Medical School, Boston, Massachusetts 02115 USA; 2Harvard Medical School and Massachusetts General Hospital Cancer Center, Charlestown, Massachusetts 02129 USA

Abstract

Interferon regulatory factor-3 (IRF-3) was found to specifically interact with HPV16 E6 in a yeast two-hybrid screen. IRF-3 is activated by the presence of double-stranded RNA or by virus infection to form a stable complex with other transcriptional regulators that bind to the regulatory elements of the IFNβ promoter. We show that IRF-3 is a potent transcriptional activator and demonstrate that HPV16 E6 can inhibit its transactivation function. The expression of HPV16 E6 in primary human keratinocytes inhibits the induction of IFNβ mRNA following Sendai virus infection. The binding of HPV16 E6 to IRF-3 does not result in its ubiquitination or degradation. We propose that the interaction of E6 with IRF-3 and the inhibition of IRF-3’s transcriptional activity may provide the virus a means to circumvent the normal antiviral response of an HPV16-infected cell.

Keywords

Footnotes

  • 3 Corresponding author.

  • E-MAIL phowley{at}warren.med.harvard.edu: FAX (617) 432-2882.

    • Received November 14, 1997.
    • Accepted April 27, 1998.
| Table of Contents

Life Science Alliance